Marketing-authorisation holder
Evolan Pharma AB
6 medicines in 2 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| APODEV 5 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG5 mg · Solución para perfusión | Apomorphine | Spain | Marketed | 2022 |
| Apomorfine hydrochloride PharmSwed 5 mg/ml, oplossing voor infusieOplossing voor infusie | Apomorphine | Netherlands | Authorised | 2012 |
| Desuric, tabletten 100 mgTablet | Benzbromarone | Netherlands | Authorised | 1972 |
| Glytrin, 400 microgram per dosis, sublinguale spraySpray voor sublinguaal gebruik | Nitroglycerin | Netherlands | Authorised | 1998 |
| Hydrocobamine 1000 microgram, oplossing voor injectie 1000 microgram/2 mlOplossing voor injectie | Hydroxocobalamin | Netherlands | Authorised | 1966 |
| URINORM 100 mg COMPRIMIDOS100 mg · Comprimido | Benzbromarone | Spain | Marketed | 1971 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 4 | 4 | 0 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antianaemic preparationsBlood and blood-forming organs · ATC B03B
- Cardiac therapyCardiovascular system · ATC C01D
- Antigout preparationsMusculo-skeletal system · ATC M04A
- Anti-Parkinson drugsNervous system · ATC N04B
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- evolan
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 6
- Countries
- 2
- Roles
- Authorisation holder